The Altria Group has filed a lawsuit for patent infringement against RJ Reynolds Vapor Co, a subsidiary of Reynolds American, over its Velo smokeless product
Japan Tobacco (JT) and Philip Morris International (PMI) are cutting the prices of their heat-not-burn (HnB) devices in Japan and planning new product launches amid the coronavirus pandemic
Altria has submitted premarket tobacco product applications (PMTAs) to the US Food and Drug Administration (FDA) for 35 varieties of its On! nicotine pouches
Big Tobacco manufacturers are expecting the effects of COVID-19 to hit hard in the second half of the year, despite a strong performance in the first quarter
Swedish Match’s sales of smoke-free products boomed in the first quarter of 2020, with the segment recording a 35% year-on-year increase to SEK2.508bn (€234m)
British American Tobacco is suing Big Tobacco rival Philip Morris International in the US and in Europe for allegedly infringing its patents with its popular heated tobacco device IQOS
Philip Morris International is braced for a significant dip in sales and use of its heated-tobacco device IQOS over the rest of 2020, with retail and travel restrictions currently imposed in nearly every country
The US tobacco industry is resisting another attempt by the FDA to impose graphic health warnings, claiming in a lawsuit that mandatory warnings would violate their rights under the First Amendment
The US International Trade Commission (USITC) is looking into a possible infringement of the patent for a nicotine pouch product, following a claim led by Swedish Match North America
Philip Morris International (PMI)’s chief financial officer, Martin King, has been promoted to the newly created role of CEO for PMI America in a bid to further develop the company’s smoke-free segment
Swedish Match is to increase production of its tobacco-free nicotine pouch ZYN to 200m cans a year after a steep rise in demand in the US
British American Tobacco (BAT)’s “modern oral” portfolio has been one of the main drivers helping the company achieve good results in 2019 for its next-generation products category, which overall increased globally by 36.9%
What benefit might there be in very low nicotine combustible cigarettes? That is the essential question the US FDA must answer in assessing a modified risk tobacco product (MRTP) application from 22nd Century Group for its VLN products